Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Transcatheter Closure of Atrial Septal Defect: Does Age Matter?

  • Kim, Nam-Kyun (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Park, Su-Jin (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Choi, Jae-Young (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System)
  • Published : 2011.11.30
⟨ Previous Next ⟩

Abstract

Atrial septal defect (ASD) is the most common type of common congenital heart disease (CHD) in adults. During the last decade, there has been a remarkable change in the treatment strategy of ASD, shifting the therapeutic gold standard from surgery to transcatheter closure, along with refinements and the evolution of device technology. Reports on the outcome of transcatheter ASD closure have shown an excellent efficacy as well as a low complication rate. However, the procedural details and/or outcomes of this procedure may be influenced by several factors including morphologic characteristics of the defect, co-morbid diseases, as well as individual factors including age and weight of the patient. Because the risk-benefit relationship in both the very young and the elderly subsets of the patients has not been clearly defined yet, closure of an ASD with device may be potentially subtracted from the treatment option in these patient groups. In this article, we will review the basis for device closure in small children and elderly patients with ASD and provide an overview of the frequently encountered problems.

Keywords

References

  1. Park MK. Pediatric Cardiology for Practitioners. 5th ed. Philadelphia: Mosby Elsevier;2008. p.161-91.
  2. Bull C, Deanfield J, de Leval M, Stark J, Taylor JF, Macartney FJ. Cor-rection of isolated secundum atrial septal defect in infancy. Arch Dis Child 1981;56:784-6. https://doi.org/10.1136/adc.56.10.784
  3. Lammers A, Hager A, Eicken A, Lange R, Hauser M, Hess J. Need for closure of secundum atrial septal defect in infancy. J Thorac Cardiovasc Surg 2005;129:1353-7. https://doi.org/10.1016/j.jtcvs.2004.10.007
  4. Hijazi ZM, Celiker A. Closure of atrial septal defects. Anadolu Kardiyol Derg 2005;5:331.
  5. Holzer R, Hijazi ZM. Interventional approach to congenital heart disease. Curr Opin Cardiol 2004;19:84-90. https://doi.org/10.1097/00001573-200403000-00003
  6. Keane JF, Lock JE, Fyler DC. Nadas' Pediatric Cardiology. 2nd ed. Philadelphia: Saunders Elsevier;2006. p.603-16.
  7. McMahon CJ, Feltes TF, Fraley JK, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter clo-sure. Heart 2002;87:256-9. https://doi.org/10.1136/heart.87.3.256
  8. Vogel M, Berger F, Dähnert I, Ewert P, Lange PE. Treatment of atrial septal defects in symptomatic children aged less than 2 years of age us-ing the Amplatzer septal occluder. Cardiol Young 2000;10:534-7.
  9. Diab KA, Cao QL, Bacha EA, Hijazi ZM. Device closure of atrial sep-tal defects with the Amplatzer septal occluder: safety and outcome in in-fants. J Thorac Cardiovasc Surg 2007;134:960-6. https://doi.org/10.1016/j.jtcvs.2007.06.018
  10. Cardenas L, Panzer J, Boshoff D, Malekzadeh Milani S, Ovaert C. Transcatheter closure of secundum atrial defect in small children. Catheter Cardiovasc Interv 2007;69:447-52. https://doi.org/10.1002/ccd.21030
  11. Choi JY, Kim NK, Park SJ, Park HK, Park YH, Sul JH. Feasibility and safety of Transcatheter closure of atrial septal defect in small child-ren weighing 10kg or less. Catheter Cardiovasc Interv 2008;1:S10. Ab-stract. https://doi.org/10.1161/CIRCINTERVENTIONS.108.765610
  12. Wood AM, Holzer RJ, Texter KM, et al. Transcatheter elimination of left-to-right shunts in infants with bronchopulmonary dysplasia is feasible and safe. Congenit Heart Dis 2011;6:330-7. https://doi.org/10.1111/j.1747-0803.2011.00540.x
  13. Amin Z. Transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv 2006;68:778-87. https://doi.org/10.1002/ccd.20872
  14. Spies C, Hijazi ZM. Transcatheter Closure of Secundum Atrial Septal Defects in the Elderly. Korean Circ J 2009;39:47-51. https://doi.org/10.4070/kcj.2009.39.2.47
  15. Schubert S, Peters B, Abdul-Khaliq H, Nagdyman N, Lange PE, Ewert P. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal de-fect. Catheter Cardiovasc Interv 2005;64:333-7. https://doi.org/10.1002/ccd.20292
  16. Swan L, Varma C, Yip J, et al. Transcatheter device closure of atrial septal defects in the elderly: technical considerations and short-term outcomes. Int J Cardiol 2006;107:207-10. https://doi.org/10.1016/j.ijcard.2005.03.027
  17. Elshershari H, Cao QL, Hijazi ZM. Transcatheter device closure of atrial septal defects in patients older than 60 years of age: immediate and follow-up results. J Invasive Cardiol 2008;20:173-6.
  18. Shah D, Azhar M, Oakley CM, Cleland JG, Nihoyannopoulos P. Na-tural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J 1994; 71:224-7. https://doi.org/10.1136/hrt.71.3.224
  19. Attie F, Rosas M, Granados N, Zabal C, Buendía A, Calderon J. Surgical treatment for secundum atrial septal defects in patients >40 years old: a randomized clinical trial. J Am Coll Cardiol 2001;38:2035-42. https://doi.org/10.1016/S0735-1097(01)01635-7
  20. Miyaji K, Furuse A, Tanaka O, Kubota H, Ono M, Kawauchi M. Sur-gical repair for atrial septal defect in patients over 70 years of age. Jpn Heart J 1997;38:677-84. https://doi.org/10.1536/ihj.38.677
  21. Shibata Y, Abe T, Kuribayashi R, et al. Surgical treatment of isolated secundum atrial septal defect in patients more than 50 years old. Ann Thorac Surg 1996;62:1096-9. https://doi.org/10.1016/0003-4975(96)00395-5
  22. Yalonetsky S, Lorber A. Comparative changes of pulmonary artery pressure values and tricuspid valve regurgitation following transcatheter atrial septal defect closure in adults and the elderly. Congenit Heart Dis 2009;4:17-20. https://doi.org/10.1111/j.1747-0803.2008.00245.x
  23. Ewert P, Berger F, Nagdyman N, et al. Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv 2001;52:177-80. https://doi.org/10.1002/1522-726X(200102)52:2<177::AID-CCD1043>3.0.CO;2-G
  24. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999;340:839-46. https://doi.org/10.1056/NEJM199903183401103
  25. Oliver JM, Gallego P, Gonzlez A, Benito F, Mesa JM, Sobrino JA. Predisposing conditions for atrial fibrillation in atrial septal defect with and without operative closure. Am J Cardiol 2002;89:39-43.
  26. Silversides CK, Siu SC, McLaughlin PR, et al. Symptomatic atrial ar-rhythmias and transcatheter closure of atrial septal defects in adult patients. Heart 2004;90:1194-8. https://doi.org/10.1136/hrt.2003.022475
  27. Taniguchi M, Akagi T, Ohtsuki S, et al. Transcatheter closure of atrial septal defect in elderly patients with permanent atrial fibrillation. Ca-theter Cardiovasc Interv 2009;73:682-6. https://doi.org/10.1002/ccd.21870
  28. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. https://doi.org/10.1056/NEJMoa021328
  29. Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation sh-ould be considered first-line therapy for some patients. Circulation 2005;112:1214-22. https://doi.org/10.1161/CIRCULATIONAHA.104.478263

Cited by

  1. Impact of hospital volume on outcomes of percutaneous ASD/PFO closure in pediatric patients vol.14, pp.4, 2011, https://doi.org/10.1007/s12519-018-0120-3
  2. Results of endovascular correction of atrial septal defect and early heart remodeling in children of preschool and school age vol.2018, pp.11, 2018, https://doi.org/10.15829/1560-4071-2018-11-27-33
  3. Risk factors for adverse events within one year after atrial septal closure in children: a retrospective follow-up study vol.30, pp.3, 2020, https://doi.org/10.1017/s1047951119002919
  4. Percutaneous atrial septal defect closure in infant weighing &lt;10 kg and having a bilateral superior vena cava: a case report vol.29, pp.3, 2011, https://doi.org/10.13181/mji.cr.192665
  5. The changes in biventricular remodelling and function after atrial septal defect device closure and its relation to age of closure vol.72, pp.1, 2011, https://doi.org/10.1186/s43044-020-00120-x